BackVor Biopharma Overview

Vor Biopharma Cost of Revenue

Cost of Revenue analysis for VOR.

Quarterly Cost of Revenue

$28000.00

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$2.13M

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)